The University of Texas Health Science Center at San Antonio
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center at San Antonio sits in the top decile of US sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count).
The University of Texas Health Science Center at San Antonio: 378 sponsored US clinical trials, 77 recruiting.
The University of Texas Health Science Center at San Antonio sponsors 378 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 264 completed. 41 of these trials are in Phase 3-4 (later-stage) and 124 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
The University of Texas Health Science Center at San Antonio ranks in the top decile of sponsors by registered trial count (#94 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
264 of 284 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
378 total, page 7 of 8
A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFNα-2A in Stage III or IV Ovarian Cancer
NCT01773889
Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste
NCT00881491
The Effect of Rifapentine on Raltegravir
NCT00809718
Treatment of Metabolic Syndrome in a Community Mental Health Center
NCT01115114
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
NCT01107717
Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds
NCT00686296
Neuroimaging of the Effects of Concerta in the Treatment of ADHD
NCT00778310
Comparative Study of Implant Surfaces to Enhance Stabilization in Patients With Type 2 Diabetes
NCT01142297
Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings
NCT00974402
A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling
NCT01740817
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
NCT00538642
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
NCT00845182
Improving Risk Factors for Diabetes Complications in Primary Care
NCT00482768
Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolar Disorder
NCT01195363
A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer
NCT00880360
Development of a Model to Evaluate Regenerative Endodontic Techniques Using Extract Human Teeth
NCT00595595
Artificial Root-End Barriers
NCT00595842
Low Dose Vasopressin in Traumatic Shock
NCT00420407
The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center
NCT00845572
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718
Study of Pain Perception Between Males and Females Following Laparoscopic Cholecystectomy
NCT00575276
Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer
NCT00348816
Sodium Channel Expression in Human Teeth
NCT00575263
Evaluation of a Radial Arterial Line's Effect on StO2 Monitoring
NCT00298090
A Medical Assistant-Based Program to Promote Healthy Behaviors in Primary Care
NCT00273806
Lamictal As Add on Treatment in Mixed States of Bipolar Disorder
NCT00223509
Evaluating the Effects of Foot Orthotics on Plantar Pressures in the Diabetic Population
NCT00240175
Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients
NCT00125229
Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes
NCT00121537
Increasing Contingency Management Success in Smoking Cessation
NCT00273793
Incidence and Factors Associated With the Development and Severity of Oral Mucositis
NCT00575809
The ABC Planning Study: Diabetes and Cardiovascular Risks in Primary Care
NCT00223340
Measurement of Bite Force in Humans
NCT00223327
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
NCT00223483
Comparison of Different Mucoactive Agents for the Care of the Intubated Patient in a Surgical Trauma Intensive Care Unit
NCT00131521
Acute Metabolic Effects of LAF 237 in Type 2 Diabetics
NCT00230464
Behavioral Intervention for Minority Adolescent Women
NCT01387646
12- Week Open Label Treatment of Refractory Bipolar Depression
NCT00223496
The Safe Teen Study
NCT00380510
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?
NCT00223522
Actos Now for Prevention of Diabetes (ACT NOW)
NCT00220961
Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
NCT00223418
Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00125203
Analysis of Enamel Wear Against Ceramic Restorations
NCT00223405
Long Term Clinical Evaluation of SLS Transtibial Sockets
NCT00167570
Molecular Mechanisms of Type 2 Diabetes Mellitus
NCT00816218
Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania
NCT00294255
Cognitive Remediation and Social Skills Training in Schizophrenia
NCT00223535
Longitudinal Endodontic Study of Apical Preparation Size
NCT00223379
Early Protein Supplementation on Prevention of Hyperkalemia
NCT00290160
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 45 |
| Phase 3 | 8 |
| Phase 4 | 33 |
Therapeutic Areas
What is open in the The University of Texas Health Science Center at San Antonio pipeline
77 recruiting of 378 indexed (20% open); 264 completed (70%).
Phase mix: 41 late (III/IV) vs 124 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The University of Texas Health Science Center at San Antonio: open-pipeline peers nationwide
Peers matched on 378 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
The University of Texas Health Science Center at San Antonio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 378 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- University of California, Irvine · 368 trials · 20% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
Sponsors near 20% open enrollment (± trial volume)
- M.D. Anderson Cancer Center · 20% recruiting · 2,692 trials
- University of Georgia · 20% recruiting · 59 trials
- University of Houston · 20% recruiting · 64 trials
- Florida International University · 20% recruiting · 89 trials
Related
What to do with this The University of Texas Health Science Center at San Antonio page
378 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center at San Antonio or any single study.
- 77 of The University of Texas Health Science Center at San Antonio's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition The University of Texas Health Science Center at San Antonio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center at San Antonio pipeline card: 378 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.